Page last updated: 2024-09-04

vatalanib and pyrazolanthrone

vatalanib has been researched along with pyrazolanthrone in 3 studies

Compound Research Comparison

Studies
(vatalanib)
Trials
(vatalanib)
Recent Studies (post-2010)
(vatalanib)
Studies
(pyrazolanthrone)
Trials
(pyrazolanthrone)
Recent Studies (post-2010) (pyrazolanthrone)
27642981,4842765

Protein Interaction Comparison

ProteinTaxonomyvatalanib (IC50)pyrazolanthrone (IC50)
Chain A, Mitogen-activated protein kinase 10Homo sapiens (human)0.15
Chain A, Mitogen-activated protein kinase 10Homo sapiens (human)0.15
Chain A, Mitogen-activated protein kinase 10Homo sapiens (human)0.15
TPA: protein transporter TIM10Saccharomyces cerevisiae S288C20.2
TPA: protein transporter TIM23Saccharomyces cerevisiae S288C6.31
Serine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)0.72
Interferon-induced, double-stranded RNA-activated protein kinaseHomo sapiens (human)8
Dual specificity protein kinase TTKHomo sapiens (human)0.8987
Mitogen-activated protein kinase 8Homo sapiens (human)0.921
Mitogen-activated protein kinase 9Homo sapiens (human)1.0111
Tyrosine-protein kinase JAK3Homo sapiens (human)0.957
Mitogen-activated protein kinase 10Homo sapiens (human)1.4193
Mitogen-activated protein kinase 14Homo sapiens (human)0.15

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atteridge, CE; Azimioara, MD; Benedetti, MG; Biggs, WH; Carter, TA; Ciceri, P; Edeen, PT; Fabian, MA; Floyd, M; Ford, JM; Galvin, M; Gerlach, JL; Grotzfeld, RM; Herrgard, S; Insko, DE; Insko, MA; Lai, AG; Lélias, JM; Lockhart, DJ; Mehta, SA; Milanov, ZV; Patel, HK; Treiber, DK; Velasco, AM; Wodicka, LM; Zarrinkar, PP1
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1

Other Studies

3 other study(ies) available for vatalanib and pyrazolanthrone

ArticleYear
A small molecule-kinase interaction map for clinical kinase inhibitors.
    Nature biotechnology, 2005, Volume: 23, Issue:3

    Topics: Benzamides; Drug Design; Escherichia coli; Escherichia coli Proteins; Imatinib Mesylate; Microchemistry; Pharmaceutical Preparations; Piperazines; Protein Binding; Protein Interaction Mapping; Protein Kinase Inhibitors; Pyrimidines

2005
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011